{
 "Susceptible": {
 "Drug": {
 "Amikacin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GI: Gall Bladder" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "None Given" ],
"percentage": [      100 ] 
} 
},
"Amoxycillin clavulanate": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GI: Gall Bladder" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "None Given" ],
"percentage": [      100 ] 
} 
},
"Aztreonam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GI: Gall Bladder" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "None Given" ],
"percentage": [      100 ] 
} 
},
"Cefepime": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GI: Gall Bladder" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "None Given" ],
"percentage": [      100 ] 
} 
},
"Ceftazidime": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GI: Gall Bladder" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "None Given" ],
"percentage": [      100 ] 
} 
},
"Ceftazidime avibactam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GI: Gall Bladder" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "None Given" ],
"percentage": [      100 ] 
} 
},
"Doripenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GI: Gall Bladder" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "None Given" ],
"percentage": [      100 ] 
} 
},
"Ertapenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GI: Gall Bladder" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "None Given" ],
"percentage": [      100 ] 
} 
},
"Imipenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GI: Gall Bladder" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "None Given" ],
"percentage": [      100 ] 
} 
},
"Levofloxacin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GI: Gall Bladder" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "None Given" ],
"percentage": [      100 ] 
} 
},
"Meropenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GI: Gall Bladder" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "None Given" ],
"percentage": [      100 ] 
} 
},
"Piperacillin tazobactam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GI: Gall Bladder" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "None Given" ],
"percentage": [      100 ] 
} 
},
"Tigecycline": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GI: Gall Bladder" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "None Given" ],
"percentage": [      100 ] 
} 
} 
},
"percentage": [ 7.692308, 7.692308, 7.692308, 7.692308, 7.692308, 7.692308, 7.692308, 7.692308, 7.692308, 7.692308, 7.692308, 7.692308, 7.692308 ],
"weight": 0.8666667,
"backgroundColor": [ "#a6cee3", "#1f78b4", "#ccebc5", "#fb9a99", "#fdbf6f", "#e7298a", "#e41a1c", "#377eb8", "#b15928", "#8dd3c7", "#bebada", "#b3de69", "#fccde5" ] 
},
"Intermediate": {
 "Drug": null,
"percentage": null 
},
"Resistant": {
 "Drug": {
 "Ampicillin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GI: Gall Bladder" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "None Given" ],
"percentage": [      100 ] 
} 
},
"Ceftaroline": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GI: Gall Bladder" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "None Given" ],
"percentage": [      100 ] 
} 
} 
},
"percentage": [       50,       50 ],
"weight": 0.1333333,
"backgroundColor": [ "#b2df8a", "#d95f02" ] 
} 
}
